AI News NQ Analysis

Notice Regarding Listing on the Tokyo Stock Exchange Growth Market

NQ Score 84/100
N1 Content Completeness 9

AI Summary (NQ-processed)

Vitabrid Japan Inc., a D2C health and beauty company known for 'VitabridC', announced its initial public offering on the Tokyo Stock Exchange Growth Market on April 2, 2026, aiming for further business expansion.

AI Analysis

Frequently Asked Questions

Q: When is Vitabrid Japan Inc. scheduled to be listed on the Tokyo Stock Exchange Growth Market?
A: Vitabrid Japan Inc. is scheduled to be listed on the Tokyo Stock Exchange Growth Market on April 2, 2026, as part of its initial public offering.
Q: What is the corporate mission of Vitabrid Japan Inc. as stated in the announcement?
A: The corporate mission of Vitabrid Japan Inc. is 'Expanding the possibilities of tomorrow.®', which guides its product development and customer-focused business approach.
Q: What product innovation enabled Vitabrid Japan Inc. to gain recognition as one of the World's 8 Promising Technologies?
A: Vitabrid Japan Inc. developed 'Vitabrid C', a powder enabling long-lasting Vitamin C packing, using special technology recognized as one of the World's 8 Promising Technologies.
Q: Which Vitabrid Japan product has ranked No.1 in sales in Japan's overall diet market for three consecutive years?
A: The functional food 'Terminalia First' by Vitabrid Japan Inc. has ranked No.1 in sales in Japan's overall diet market for three consecutive years.
Q: What business philosophy does Vitabrid Japan Inc. emphasize in its customer-focused strategy?
A: Vitabrid Japan Inc. emphasizes the philosophy of 'Optimal rather than Maximal®', prioritizing personalized matching with individual customers over mass-market solutions.